{"nct_id":"NCT01590459","title":"24-week Study With Open Label Extension of VX-509, an Oral JAK3 Inhibitor, in Subjects Taking Methotrexate","status":"COMPLETED","status_verified_date":"2015-10","start_date":"2012-04","start_date_type":null,"primary_completion_date":"2014-07","primary_completion_date_type":"ACTUAL","completion_date":"2014-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["VRTX"]}